Douglas Lane & Associates, LLC Bristol Myers Squibb CO Transaction History

Douglas Lane & Associates, LLC

$6.79 Billion
Q1 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 1,769,211 shares of BMY stock, worth $71.6 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

1,769,211

Previous 1,724,181 2.61%

Holding current value

$71.6 Million

Previous $88.5 Million 8.45%

% of portfolio

1.41%

Previous 1.39%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$47.98 - $54.4 $2.16 Million - $2.45 Million	45,030 Added 2.61%	1,769,211 $95.9 Million
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $451,688 - $538,988	-9,317 Reduced 0.54%	1,724,181 $88.5 Million
Q3 2023 Oct 16, 2023	BUY	$57.89 - $64.73 $1.55 Million - $1.74 Million	26,861 Added 1.57%	1,733,498 $101 Million
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $809,881 - $899,246	-12,712 Reduced 0.74%	1,706,637 $109 Million
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $1.27 Million - $1.44 Million	-19,295 Reduced 1.11%	1,719,349 $119 Million

Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $406,565 - $481,431	-5,937 Reduced 0.34%	1,738,644 $125 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $6.61 Million - $7.83 Million	-96,544 Reduced 5.24%	1,744,581 $126 Million
Q3 2022 Oct 14, 2022	SELL	$0.13 - $76.84 $5,043 - $2.98 Million	-38,795 Reduced 2.06%	1,841,125 $131 Million
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $2.81 Million - $3.09 Million	-38,663 Reduced 2.02%	1,879,920 $145 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $1.12 Million - $1.34 Million	18,197 Added 0.96%	1,918,583 $140 Million
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $3.84 Million - $4.48 Million	71,657 Added 3.92%	1,900,386 $118 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $1.28 Million - $1.5 Million	21,593 Added 1.19%	1,828,729 $108 Million
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $1.52 Million - $1.66 Million	24,607 Added 1.38%	1,807,136 $121 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $816,696 - $918,542	13,763 Added 0.78%	1,782,529 $113 Million
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $2.22 Million - $2.51 Million	-38,399 Reduced 2.12%	1,768,766 $110 Million
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $1.94 Million - $2.14 Million	-33,696 Reduced 1.83%	1,807,165 $109 Million
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $4.6 Million - $5.37 Million	-83,822 Reduced 4.36%	1,840,861 $108 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $6.13 Million - $8.92 Million	-132,218 Reduced 6.43%	1,924,683 $107 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $35.7 Million - $46.5 Million	724,940 Added 54.43%	2,056,901 $132 Million
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $1.09 Million - $1.29 Million	25,458 Added 1.95%	1,331,961 $67.5 Million
Q2 2019 Jul 08, 2019	BUY	$44.62 - $49.34 $2.24 Million - $2.47 Million	50,162 Added 3.99%	1,306,503 $59.3 Million
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $212,831 - $253,774	4,717 Added 0.38%	1,256,341 $59.9 Million
Q4 2018 Jan 17, 2019	BUY	$48.76 - $63.23 $1.3 Million - $1.69 Million	26,656 Added 2.18%	1,251,624 $65.1 Million
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $2.03 Million - $2.29 Million	36,722 Added 3.09%	1,224,968 $76 Million
Q2 2018 Jul 23, 2018	BUY	$50.53 - $62.98 $10.6 Million - $13.2 Million	209,237 Added 21.37%	1,188,246 $65.8 Million
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $3.2 Million - $3.68 Million	53,419 Added 5.77%	979,009 $61.9 Million
Q4 2017 Jan 24, 2018	BUY	$59.94 - $65.35 $3.61 Million - $3.94 Million	60,299 Added 6.97%	925,590 $56.7 Million
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $47.8 Million - $55.2 Million	865,291	865,291 $55.2 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Bristol Myers Squibb CO Transaction History